(2025)
Aspergillus terreus sectorization: a morphological phenomenon shedding light on amphotericin B resistance mechanism.
mBio 16(4),
e0392624.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Mikrobiom bei Gesundheit und Krankheit
- Systembiologie von Infektionskrankheiten
- Personalisierte Ernährung
Publikationen
(2025)
Antibacterial siderophores of Pandoraea pathogens and their impact on the diseased lung microbiota.
Angew Chem Int Ed 64(24),
e202505714.
(2025)
A bioenergetic basis for multiorgan dysfunction in sepsis.
bioRxiv
[Preprint]
(2025)
The murine lung microbiome is disbalanced by the human-pathogenic fungus Aspergillus fumigatus resulting in enrichment of anaerobic bacteria.
Cell Rep 44(3),
115442.
(2025)
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease.
Microbiome 13(1),
10.
(2025)
An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial
Nature Medicine 31(7),
2255-2268.
(2025)
Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models.
Pharmacol Res 212,
107581.
(2025)
Unveiling immune interference: how the dendritic cell response to co-infection with Aspergillus fumigatus is modulated by human cytomegalovirus and its virokine CMVIL-10.
mBio
[Epub ahead of print]
(2025)
Chemical pollution drives taxonomic and functional shifts in marine sediment 2 microbiome, influencing benthic metazoans.
ISME Commun 5(1),
ycae141.
(2025)
Multi-omics and -organ insights into energy metabolic adaptations in early sepsis onset.
Advanced Science
[Epub ahead of print]